Synthetic studies on the extracellular domain of the T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) using Trt-K10 solubilizing tags

Bioorg Med Chem. 2024 Feb 1:99:117585. doi: 10.1016/j.bmc.2023.117585. Epub 2023 Dec 30.

Abstract

The T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) is an inhibitory immunoreceptor expressed on lymphocytes that serves as a promising target for cancer immunotherapy. In this study, facile synthetic protocols to produce the extracellular domain of TIGIT were investigated for applications of TIGIT in mirror-image screening. During the synthesis via sequential native chemical ligations, we encountered problems with significantly poor solubility of the ligated products. Introducing trityl-type solubilizing auxiliaries, which also functioned as temporary protecting groups for cysteine residues, facilitated a flexible order of ligations and efficient purification protocols. After refolding under appropriate conditions, the synthetic TIGIT showed a sufficient affinity toward its target ligand CD155.

Keywords: CD155; Chemical protein synthesis; Solubilizing tag; T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain; TIGIT.

MeSH terms

  • Immunoglobulins*
  • Immunotherapy
  • Receptors, Immunologic
  • T-Lymphocytes*
  • Tyrosine

Substances

  • Immunoglobulins
  • Receptors, Immunologic
  • Tyrosine